Core Viewpoint - The article emphasizes the importance of the Fourth Protein Science and Antibody Discovery Symposium, focusing on protein innovation and accelerating industry development, scheduled for November 21, 2025, in Shanghai Zhangjiang [4][21]. Group 1: Event Overview - The symposium aims to create a high-quality platform for early-stage research, emphasizing technology implementation and data exchange [5]. - The event will feature a main forum and two sub-forums focusing on autoimmune and tumor drug development, as well as complex antibodies and protein engineering [5][6]. - Key topics include trends in emerging targets, next-generation tumor immunology, and various strategies for antibody drug development [5][6]. Group 2: Participants and Contributions - The symposium will gather experts from leading companies, including CSOs, CTOs, and R&D directors, to share the latest research findings and practical experiences [7]. - The event is free for pharmaceutical companies and research institutions, with a focus on scientists and relevant R&D personnel [23]. Group 3: Organizers and Collaborators - The symposium is initiated by WuXi Biologics and supported by partners such as GENEWIZ, ACROBiosystems, and Agilent [21]. - The collaboration aims to enhance the scientific community's engagement and foster innovation in biopharmaceutical research [21][24].